FDA Adverse Event Death Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 2874998 · Received December 17, 2012

Report

Report Number
9612164-2012-01781
Event Type
Death
Date Received
December 17, 2012
Date of Event
November 18, 2012
Report Date
January 17, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DATE OF DEATH CHANGED FROM 4 DAYS POST IMPLANT OF MEDTRONIC STENTS TO 5 DAYS POST IMPLANT.

Additional Manufacturer Narrative · 1

RESULTS: INHERENT RISK OF PROCEDURE (DEATH, OCCLUSION); DEVICE OR IMAGES NOT RETURNED FOR EVALUATION. CONCLUSIONS: INHERENT RISK OF PROCEDURE (DEATH, OCCLUSION). (B)(4).

Description of Event or Problem · 1

PCI WAS PERFORMED ON PATIENT WITH AMI; PHYSICIAN DEPLOYED ONE NON-MEDTRONIC STENT TO RCA. APPROXIMATELY ONE WEEK LATER PHYSICIAN SUCCESSFULLY DEPLOYED 2 RESOLUTE INTEGRITY DRUG-ELUTING STENTS TO LAD DURING A PLANNED PCI. APPROXIMATELY 4 DAYS LATER PATIENT SUFFERED CARDIOPULMONARY ARREST, CAG SHOWED OCCLUSION IN LAD. ASPIRATION WAS PERFORMED ON THE PATIENT, BUT THEY EXPIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND 0006203170

Patients

Seq Age Sex Outcome Treatment
1 00049 YR Death CLOPIDOGREL AND ASPIRIN.